Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: A randomised trial

Lancet

Volumn 353, Issue 9149, 1999, Pages 267-272

  Dearnaley, David P ^a   Khoo, Vincent S ^a   Norman, Andrew R ^a   Meyer, Lesley ^b   Nahum, Alan ^a   Tait, Diana ^a   Yarnold, John ^a   Horwich, Alan ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER FUNCTION; CANCER CONTROL; CANCER RADIOTHERAPY; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; RADIATION DOSE; RECTUM; RECTUM HEMORRHAGE; RISK ASSESSMENT;

EID: 0033026308     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05180-0     Document Type: Article

References (32)

1. Fuks Z, Horwich A Clinical and technical aspects of conformal therapy. Radiother Oncol. 29:1993;219-220.
2. Niemierko A, Goitein M Modeling of normal tissue response to radiation: the critical volume model. Int J Radiot Oncol Biol Phys. 25:1993;135-145.
3. Mettlin C Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer Studies, 1974-1993. Prostate. 32:1997;221-226.
4. Hanks GE, Schultheiss TE, Hunt MA, Epstein B Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 31:1995;25-29.
5. Vijayakumar S, Awan A, Karrison Tet al. Acute toxicity during external-beam radiotherapy for localized prostate cancer: comparison of different techniques. Int J Radiat Oncol Phys. 25:1993;359-371.
6. Leibel SA, Heimann R, Kutcher GJet al. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study. Int J Radiat Oncol Biol Phys. 28:1994;55-65.
7. Sandler HM, McLaughlin PW, Ten Haken RK, Addision H, Forman J, Lichter A Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys. 33:1995;797-801.
8. Williams MV, Denekamp J, Fowler JF Dose response relationships for human tumours: implications for clinical trials of dose modifying agents. Int J radiat Oncol Biol Phys. 10:1984;1703-1707.
9. Zelefsky MJ, Leibel SA, Gaudin PBet al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
10. Hanks GE, Hanlon AL, Schultheiss TEet al. Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 41:1998;501-510.
11. Tait DM, Nahum AE, Meyer LCet al. Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment. Radiother Oncol. 42:1997;121-136.
12. Huddart RA, Nahum A, Neal Aet al. Accuracy of pelvic radiotherapy: prospective analysis of 90 patients in a randomised trial of blocked versus standard radiotherapy. Radiother Oncol. 39:1996;19-29.
13. Mayles WPM, Chow M, Dyer Jet al. The Royal Marsden Hospital pelvic radiotherapy trial: technical aspects and quality assurance. Radiother Oncol. 29:1993;184-191.
14. Shearer RJ, Davies JH, Gelister JS, Dearnaley DP Hormonal cytoreduction and radiotherapy for carcinoma of the prostate. Br J Urol. 69:1992;521-524.
15. Pilepich MV, Krall JM, al-Sarraf M, John MJ, Doggett RL, Sause WT Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomised comparative trial of RTOG. Urology. 45:1995;616-623.
16. Laverdiere J, Gomez JL, Cusan Let al. Beneficial effect of combination hormonal therapy administered prior and following external beam radiation therapy in localized prostate cancer. Int J Radiat Oncol Biol Phys. 37:1997;247-252.
17. ICRU Report 50. Prescribing, recording and reporting photon beam therapy. Bethesda, MD: International Commission for Radiation Units and Measurements. 1993.
18. Lawton CA, Won M, Pilepich MVet al. Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706. Int J Radiat Oncol Biol Phys. 21:1991;935-939.
19. Boring CC, Squires TS, Tong T, Montgomery S Cancer statistics, 1994. CA Cancer J Clin. 44:1994;7-26.
20. Dearnaley DP, Melia J Early prostate cancer - to treat or not to treat? Lancet. 349:1997;892-893.
21. Middleton RG, Thompson IM, Austenfeld MSet al. Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol. 154:1995;2144-2148.
22. Lu-Yao GL, Greenberg RE Changes in prostate cancer incidence and treatment in USA. Lancet. 343:1994;251-254.
23. Sailer SL, Rosenman JG, Symon JR, Cullip TJ, Chaney EL The tetrad and hexad: maximum beam separation as a starting point for noncoplanar 3-D treatment planning: prostate cancer as a test case. Int J Radiat Oncol Biol Phys. 30:1994;439-446.
24. Ten Haken RK, Perez-Tamayo C, Tesser RJ, McShan DL, Fraass BA, Lichter AS Boost treatment of the prostate using shaped, fixed fields. Int J Radiat Oncol Biol Phys. 16:1989;193-200.
25. Oldham M, Webb S The optimization and inherent limitations of 3D conformal radiotherapy treatment plans of the prostate. Br J Radiol. 68:1995;882-893.
26. Neal AJ, Oldham M, Dearnaley DP Comparison of treatment techniques and conformal radiotherapy of the prostate using dose-volume histograms and normal tissue complication probabilities. Radiother Oncol. 37:1995;29-34.
27. Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH Prediction of normal-tissue tolerance to radiotherapy from in-vitro cellular radiation sensitivity. Lancet. 339:1992;1570-1571.
28. LENT SOMA tables. Radiother Oncol 1995; 35: 17-60.
29. Cella DF, Tulsky DS, Gray Get al. The functional assessment of cancer therapy scale: development and validation of the general medicine. J Clin Oncol. 11:1993;570-579.
30. Litwin MS, Hays RD, Fink A Quality of life outcomes in men treated for localized prostate cancer. JAMA. 273:1995;129-135.
31. Pollack A, Zagars GK, Starkschall Get al. Conventional vs conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity. Int J Radiat Oncol Biol Phys. 34:1996;555-564.
32. Nguyen LN, Pollack A, Zagars GK Late effects after radiotherapy for prostate cancer in a randomised dose-response study: results of a self-assessment questionnaire. Urology. 51:1998;991-997.